Virtual Pitch Day
Profiting from the CBD Market in the UK and Europe
Live webinar with Peter Shippen,
CEO of Brittania Bud Company
Thursday, June 25, 2020
We are a UK-focused company providing services and consulting in the areas of cosmetics, food and nutraceutical products. We stand to significantly profit in the immediate term from the regulation and rationalization of the CBD market in the UK and Europe and believe we will be a global leader in CBD formulations related to skin care.
We are also developing a global supply chain to provide European companies with ingredients, formulations and testing to develop cosmetics, food and nutraceutical products containing CBD.
We are acquiring a controlling stake of a business that generate £1.6mm of pre-tax earnings last year, and believe we can double earnings in the year ahead.
Peter Shippen is CEO of Britannia Bud Company, a UK-focused cannabis company founded in 2019.
Peter is British-born, Canadian-raised entrepreneur known for his work in the Canadian financial services industry. Prior to identifying the UK as an emerging market in the cannabis space and founding Britannia Bud Company, Peter was CEO of Redwood Asset Management a company that launched Canada’s first mutual fund and actively managed ETF focused on investment in the cannabis industry. In 2018, Redwood amalgamated with Purpose Investments, a company that launched Europe’s first cannabis ETF in 2020.
Peter holds the Chartered Financial Analyst Designation and the Chartered Alternative Analyst designation. He recently completed the ICD Rotman Directors Education Program at the University of Toronto and is a holder of the ICD.D designation.